10 May 2024
Clean Power Hydrogen plc
("CPH2", the "Company" or the "Group")
Posting of Annual Report and Notice of Annual General Meeting
CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), announces that the Company's 2024 Annual General Meeting ("AGM") will be held at The Royal Suite, Doncaster Racecourse, Leger Way, Doncaster, DN2 6BB at 11.00am on Wednesday 19 June 2024. The Notice of AGM has been posted to shareholders and is available on the Company's shareholders website at www.cph2.com/investors/financial-calendar.
The Company's 2023 Annual Report, has also been posted to shareholders and is available on the Company's website at https://www.cph2.com/investors/annual-interim-reports.
For more information, please contact:
Clean Power Hydrogen plc | via Camarco |
Jon Duffy, Chief Executive Officer James Hobson, Chief Financial Officer | |
| |
Cavendish Capital Markets Limited - NOMAD & Broker | |
Neil McDonald | +44 (0)131 220 9771 |
Peter Lynch | +44 (0)131 220 9772 |
Adam Rae | +44 (0)131 220 9778 |
| |
Camarco PR | + 44(0) 20 3 757 4980 |
Billy Clegg | |
Owen Roberts | |
Lily Pettifar | |
To find out more, please visit: https://www.cph2.com
Overview of CPH2
CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.